Aclaris Therapeutics to Attend Upcoming Investor C
Post# of 301275
MALVERN, Pa., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a clinical-stage pharmaceutical company, today announced that members of its management team will present and host investor meetings at the following upcoming investor events:
Dr. Neal Walker, President and Chief Executive Officer, will present at LEERINK Partners 6 th Annual Global Healthcare Conference in New York, NY on Wednesday, February 15, 2017, at 10:30 AM EST at the Lotte New York Palace Hotel in New York.
Dr. Walker will also present at the Cowen and Company 37th Annual Healthcare Conference in Boston, MA on Tuesday, March 7, 2017 at 11:20 AM EST at the Boston Marriott Copley Place in Boston.
A live webcast of the presentations will be available on the Events and Webcasts section of the Company's website, http://www.aclaristx.com/events-and-webcasts . A replay will also be available after the event.
About Aclaris Therapeutics, Inc. Aclaris Therapeutics, Inc. is a clinical-stage dermatologist-led pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting the Aclaris website at www.aclaristx.com .
Contact: Aclaris Contact Michael Tung, M.D. Vice President / Investor Relations 484-329-2140 mtung@aclaristx.com Media Contact Mariann Caprino TogoRun 917-242-1087 M.Caprino@togorun.com
(0)
(0)